Lv53
1150 积分 2023-11-20 加入
我国主要神经系统自身免疫性疾病的发病率
16天前
已完结
NGS and FISH for MET amplification detection in EGFR TKI resistant non-small cell lung cancer (NSCLC) patients: A prospective, multicenter study in China
26天前
已完结
Robotic Lobectomy Is Cost-effective and Provides Comparable Health Utility Scores to Video-assisted Lobectomy
10个月前
已完结
Biomarkers of response to immunotherapy in early stage non-small cell lung cancer
10个月前
已完结
Rapid Advances in Resectable Non–Small Cell Lung Cancer
10个月前
已完结
Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial
11个月前
已完结
Durvalumab plus platinum–etoposide versus platinum–etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial
11个月前
已完结
Immune-checkpoint inhibition for resectable non-small-cell lung cancer — opportunities and challenges
11个月前
已完结
A prospective randomized study of various irradiation doses and fractionation schedules in the treatment of inoperable non-oat-cell carcinoma of the lung. Preliminary report by the radiation therapy oncology group
1年前
已完结
Adjuvant atezolizumab after adjuvant chemotherapy in resected stage IB–IIIA non-small-cell lung cancer (IMpower010): a randomised, multicentre, open-label, phase 3 trial
1年前
已完结
皖公网安备34019202002308
